Of note, Blimp-1 expression is not restricted to hematopoietic cells but is also found in breast cancer cells [50], lung cancer cells [57], or inflammatory synoviocytes [58], where it is upregulated by various factors, derived from the micromilieu and associated with disease progression. Here, PRDM1 is linked to lung carcinoma.